We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Endo Subsidiaries Sue FDA to Have Agency’s Compounding Decree Declared Illegal
Endo Subsidiaries Sue FDA to Have Agency’s Compounding Decree Declared Illegal
Two Endo International subsidiaries sued the FDA last week to have the agency’s bulk drug compounding decree on compounding operations declared illegal and to halt compounding involving the API vasopressin.